Form D · Biotechnology
Kodiak Sciences Inc.
Palo Alto, CA · CIK 0001468748
Offering snapshot reported Mar 24, 2016 · SEC filing
- Reported sold
- $34M Offering amount: $34M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 8, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 24, 2016 | Initial | $33,960,000 | No comparison | 13 | SEC filing |
| Jul 28, 2009 | Initial | $1,836,044 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-259894
Source: Form D, filed Mar 24, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Borgeson | Executive |
| Steven Charles | Director, Executive |
| Victor Perlroth | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2631 Hanover Street
Palo Alto, CA, 94304
Palo Alto, CA, 94304